Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 10,000 | |||
5 mg | 在庫あり | ¥ 21,000 | |||
10 mg | 在庫あり | ¥ 36,500 | |||
25 mg | 在庫あり | ¥ 48,000 | |||
50 mg | 在庫あり | ¥ 61,000 | |||
100 mg | 在庫あり | ¥ 105,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 25,500 |
説明 | PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. |
In vivo | PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat[3]. |
分子量 | 555.6 |
分子式 | C31H30FN5O4 |
CAS No. | 2230198-02-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (224.98 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-06882961 2230198-02-2 GPCR/G Protein Glucagon Receptor PF06882961 PF 06882961 Inhibitor inhibitor inhibit